High-end Vaccine announced August revenue of 102 million yuan, an annual increase of 24154.42%, a new high since February 2022, mainly benefiting from the shipment of enterovirus 71 vaccine. Li Sixian, vice president and spokesperson of High-end Vaccine, said that the publicly funded influenza vaccine is expected to The vaccine will be launched in October, and high-end vaccines will start to attract shipments in September. After this wave is completed, the third batch of enterovirus 71 vaccine will be sealed and inspected.
Not long after school started in Taiwan in September, enterovirus is in its epidemic period, and many parents have already taken their children to get the enterovirus 71 vaccine. Li Sixian pointed out that the first batch of high-end vaccine enterovirus 71 vaccine in August, with a total of 20,123 doses, was successfully completed. The second batch of more than 20,000 doses was completed shortly after the delivery. Since enterovirus has become a prevalent disease throughout the year, the legal person is optimistic about the follow-up momentum.
Taiwan will start administering publicly funded quadrivalent influenza vaccines in October. This year’s total procurement volume is 6.986,900 doses, of which 707,000 doses of high-end vaccines have been awarded, accounting for 10.1% of the total. This is the first time that high-end vaccines have been put into the ranks of publicly funded influenza vaccines. Li Sixian pointed out, It is expected that the supply momentum of publicly funded influenza vaccines will begin in September.
Li Sixian emphasized that this year there has been a serious enterovirus epidemic around the world, so the first batch of enterovirus 71 vaccines has been administered as soon as it enters the market. It is expected that after the flu vaccine is completed, the third batch of enterovirus 71 vaccine will be sealed and tested, and follow-up The Food and Drug Administration of the Ministry of Health and Welfare will determine the time to put it on the market after inspecting the progress.
(Source of first picture: High-end Vaccine)
Further reading:
2023-09-13 11:09:58
#Highend #vaccine #revenue #increased #yearonyear #AugustInfluenza #vaccine #sales #start #October #kickstarting #sales #momentum
